The rising use of GLP-1 weight-loss medications such as Ozempic is reshaping the U.S. apparel market as retailers experience a shift in size demand and increasing returns.
Claire’s journey — from bankruptcy to its recent acquisition by a private equity firm — has been a rollercoaster for one of the most recognizable names in accessories.